Quantitative microcomputed tomography assessment of intratrabecular, intertrabecular, and cortical bone architecture in a rat model of severe renal osteodystrophy

Journal of Computer Assisted Tomography

Volumn 31, Issue 2, 2007, Pages 320-328

  Hopper, Tim A J ^a,b   Wehrli, Felix W ^b   Saha, Punam K ^a,b,c,g   Andre, Jalal B ^a,c,h   Wright, Alexander C ^b   Sanchez, Cheryl P ^d   Leonard, Mary B ^e,f  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g UNIVERSITY OF IOWA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Micro CT; Microarchitecture; Renal osteodystrophy

Indexed keywords

BONE; COMPUTER ARCHITECTURE; COMPUTERIZED TOMOGRAPHY; RATS; TOPOLOGY;

BONE ARCHITECTURE; BONE VOLUME; CORTICAL BONE; MICRO ARCHITECTURES; MICRO COMPUTED TOMOGRAPHY (MICRO-CT); MICRO CT; RAT MODEL; RENAL OSTEODYSTROPHY; TRABECULAR BONES; TRABECULAR THICKNESS;

POROSITY;

CALCITRIOL; GROWTH HORMONE; PHOSPHORUS;

ALGORITHM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE STRUCTURE; CANADA; CONTROLLED STUDY; CORTICAL BONE; DIAGNOSTIC IMAGING; DIET; DISEASE SEVERITY; FEMUR; IMAGE PROCESSING; MALE; METAPHYSIS; MICRO-COMPUTED TOMOGRAPHY; NEPHRECTOMY; NONHUMAN; POROSITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RENAL OSTEODYSTROPHY; TRABECULAR BONE;

EID: 34147107553     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rct.0000238007.19258.3d     Document Type: Article

References (38)

1. Alem AM, Sherrard DJ, Gillen DL, et al. Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int. 2000;58:396-399.
2. Parfitt AM. A structural approach to renal bone disease. J Bone Miner Res. 1998;13:1213-1220.
3. Rauch F, Schoenau E. Changes in bone density during childhood and adolescence: an approach based on bone's biological organization. J Bone Miner Res. 2001;16:597-604.
4. Sanchez CP, Kuizon BD, Abdella PA, et al. Impaired growth, delayed ossification, and reduced osteoclastic activity in the growth plate of calcium-supplemented rats with renal failure. Endocrinology. 2000;141:1536-1544.
5. Langman CB, Mazur AT, Baron R, et al. 25-Hydroxyvitamin D3 (calcifediol) therapy of juvenile renal osteodystrophy: beneficial effect on linear growth velocity. J Pediatr. 1982;100:815-820.
6. Fine RN. Growth hormone treatment of children with chronic renal insufficiency, end-stage renal disease and following renal transplantation- update 1997. J Pediatr Endocrinol Metab. 1997;10:361-370.
7. Watkins SL. Is severe renal osteodystrophy a contraindication for recombinant human growth hormone treatment? Pediatr Nephrol. 1996;10:351-354.
8. Bonse U, Busch F, Gunnewig O, et al. 3D computed X-ray tomography of human cancellous bone at 8 microns spatial and 10(-4) energy resolution. Bone Miner. 1994;25:25-38.
9. Laib A, Barou O, Vico L, et al. 3D micro-computed tomography of trabecular and cortical bone architecture with application to a rat model of immobilisation osteoporosis. Med Biol Eng Comput. 2000;38:326-332.
10. Martin-Badosa E, Amblard D, Nuzzo S, et al. Excised bone structures in mice: imaging at three-dimensional synchrotron radiation micro CT. Radiology. 2003;229:921-928.
11. Salome M, Peyrin F, Cloetens P, et al. A synchrotron radiation microtomography system for the analysis of trabecular bone samples. Med Phys. 1999;26:2194-2204.
12. Jiang Y, Zhao JJ, Mitlak BH, et al. Recombinant human parathyroid hormone (1-34) (teriparatide) improves both cortical and cancellous bone structure. J Bone Miner Res. 2003;18:1932-1941.
13. Sato M, Westmore M, Ma YL, et al. Teriparatide (PTH[1-34]) strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity. J Bone Miner Res. 2004;19:623-629.
14. Sanchez CP, Salusky IB, Kuizon BD, et al. Growth of long bones in renal failure: roles of hyperparathyroidism, growth hormone and calcitriol. Kidney Int. 1998;54:1879-1887.
15. Saha PK, Chaudhuri BB. Detection of 3D simple points for topology preserving transformation with application to thinning. IEEE Trans Pattern Anal Mach Intell. 1994;16:1028-1032.
16. Kong TY, Rosenfeld A. Digital topology: introduction and survey. Comput Vis Graph Image Process. 1989;48:357-393.
17. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987;2:595-610.
18. Saha PK, Wehrli FW. Measurement of trabecular bone thickness in the limited resolution regime of in vivo MRI by fuzzy distance transform. IEEE Trans Med Imaging. 2004;23:53-62.
19. Saha PK, Wehrli FW, Gomberg BR. Fuzzy distance transform-theory, algorithms, and applications. Comput Vis Image Underst. 2002;86:171-190.
20. Schober HC, Han ZH, Foldes AJ, et al. Mineralized bone loss at different sites in dialysis patients: implications for prevention. J Am Soc Nephrol. 1998;9:1225-1233.
21. Nuzzo S, Lafage-Proust MH, Martin-Badosa E, et al. Synchrotron radiation microtomography allows the analysis of three-dimensional microarchitecture and degree of mineralization of human iliac crest biopsy specimens: effects of etidronate treatment. J Bone Miner Res. 2002;17:1372-1382.
22. Bousson V, Peyrin F, Bergot C, et al. Cortical bone in the human femoral neck: three-dimensional appearance and porosity using synchrotron radiation. J Bone Miner Res. 2004;19:794-801.
23. Turner RT, Kidder LS, Kennedy A, et al. Moderate alcohol consumption suppresses bone turnover in adult female rats. J Bone Miner Res. 2001;16:589-594.
24. Bourrin S, Ammann P, Bonjour JP, et al. Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats. Bone. 2002;30:195-200.
25. Bourrin S, Toromanoff A, Ammann P, et al. Dietary protein deficiency induces osteoporosis in aged male rats. J Bone Miner Res. 2000;15:1555-1563.
26. Takahashi M, Wehrli FW, Wehrli SL, et al. Effect of prostaglandin and bisphosphonate on cancellous bone volume and structure in the ovariectomized rat studied by quantitative three-dimensional nuclear magnetic resonance microscopy. J Bone Miner Res. 1999;14:680-689.
27. Iwamoto J, Yeh JK, Takeda T. Effect of vitamin K2 on cortical and cancellous bones in orchidectomized and/or sciatic neurectomized rats. J Bone Miner Res. 2003;18:776-783.
28. Lane NE, Haupt D, Kimmel DB, et al. Early estrogen replacement therapy reverses the rapid loss of trabecular bone volume and prevents further deterioration of connectivity in the rat. J Bone Miner Res. 1999;14:206-214.
29. Ma YL, Bryant HU, Zeng Q, et al. Long-term dosing of arzoxifene lowers cholesterol, reduces bone turnover, and preserves bone quality in ovariectomized rats. J Bone Miner Res. 2002;17:2256-2264.
30. David V, Laroche N, Boudignon B, et al. Noninvasive in vivo monitoring of bone architecture alterations in hindlimb-unloaded female rats using novel three-dimensional microcomputed tomography. J Bone Miner Res. 2003;18:1622-1631.
31. Uzawa T, Hori M, Ejiri S, et al. Comparison of the effects of intermittent and continuous administration of human parathyroid hormone(1-34) on rat bone. Bone. 1995;16:477-484.
32. Lee LL, Lee JS, Waldman SD, et al. Polycyclic aromatic hydrocarbons present in cigarette smoke cause bone loss in an ovariectomized rat model. Bone. 2002;30:917-923.
33. Williams S, Wakisaka A, Zeng QQ, et al. Minocycline prevents the decrease in bone mineral density and trabecular bone in ovariectomized aged rats. Bone. 1996;19:637-644.
34. Hopper TA, Meder R, Pope JM. Comparison of high-resolution MRI, optical microscopy and SEM for quantitation of trabecular architecture in the rat femur. Magn Reson Imaging. 2004;22:953-961.
35. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis. 2000;35:S1-S140.
36. Eknoyan G, Levin A, Levin NW. Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42:1-201.
37. Suda T, Ueno Y, Fujii K, et al. Vitamin D and bone. J Cell Biochem. 2003;88:259-266.
38. Altundag O, Altundag K, Selim Silay Y, et al. Calcium and vitamin D supplementation during bisphosphonate administration may increase osteoclastic activity in patients with bone metastasis. Med Hypotheses. 2004;63:1010-1013.